What our listeners are saying:
“Great podcast! My favorite one about cancer. I learn so much from this one and love all the guest speakers.”
Anursern
Listen to our most recent podcast episodes and view show notes for more information and links to helpful resources discussed in each episode.
Recent federal legislation about health insurance coverage will impact the breast cancer community. Monica Bryant of Triage Cancer talks to us about changes to private insurance (through the ACA healthcare exchange marketplace) and publicly funded insurance including Medicare and Medicaid. We also discuss some of the potential ripple effects, including on cancer screening programs, that may impact the ability of many in the cancer community to access healthcare.
Palliative care is often misunderstood. Many assume it’s only for the end of life, but it’s really about improving quality of life, managing symptoms, and helping you live as fully and comfortably as possible at any stage of metastatic breast cancer (MBC). In this episode, we talk with Dr. Jones, a palliative care physician who brings both medical expertise and deep compassion for the MBC community, and we cover what palliative care actually is, how to access it, and why integrating it early can make a meaningful difference
Our annual “We Remember” episode honors all who died from metastatic breast cancer since last October and gives voice to the grief and love that endures after each death. Each name shared is a tiny marker of a full & beloved life and each one leaves behind an expansive network of loved ones. For those of us in the MBC community, the loss of our friends is particularly devastating & the cumulative losses are heavy. You are not alone in your grief. We invite you to gather with us to honor the individual lives lost in the last year, and to acknowledge and provide space for the grief we collectively feel.
In our Season 11 opening episode, we’re bringing you the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research and explains what it could mean for people living with MBC.
Join us for a candid & heartfelt discussion with certified death doula and fellow MBCer Deltra James as she shares how death doulas support us in facing mortality with less fear and more intention. We also chat about her six week virtual course, “The Good Grim: Exploring end of life, facing fears, and living fiercely”, offered free through Project Life for those living with MBC. We invite you to listen to this life-filled conversation.
In this episode of Our MBC Life, we sit down with Dr. Kelly Shanahan, the president of METAvivor, a U.S. nonprofit solely dedicated to funding research for metastatic breast cancer (MBC) while also supporting patients through advocacy and community. Our guest shares METAvivor’s mission, their biggest milestones, and how their work is driving critical research that aims to extend lives and improve quality of life for those living with MBC.
We dive into how METAvivor prioritizes research funding, the importance of patient involvement in advocacy initiatives, and the Stage IV Stampede—a powerful advocacy event raising awareness and amplifying the voices of the MBC community.
Tune in to hear how METAvivor is shaping the future of MBC advocacy and how you can get involved to make an impact.
This episode of Our MBC Life features Stephanie Walker and Julia Maués of the Patient-Centered Dosing Initiative team who have been working on the 2025 reboot of its groundbreaking 2020 patient survey. Julia and Stephanie break down how treatment doses are typically determined during clinical trials and why individualized dosing, based on more than your diagnosis, is so important for people living with metastatic breast cancer. They also chat about the newly launched 2025 Patient Dosing Survey that you can take right now, where to find it and why your experience about metastatic breast cancer treatment matters.
Senior Producer & Host Martha Carlson interviews Josh Newby, the founder of Theresa’s Research Foundation. Josh has been a leader in the world of metastatic breast cancer advocacy for over a decade, focusing energy on bringing MBC research scientists and patient advocates together in an effort to improve our lives. To paraphrase Josh, researchers need patients and patients need researchers—a synergy he recognized early and brought to the fore of advocacy. This year, Josh and Theresa’s Research Foundation is doubling down on a cure for MBC. In this episode, he talks about the work the Foundation is doing and what “cure” means to him. He also talks about the effects of current federal policy on research and what it may mean for the young MBC investigators he champions.
Welcome to our Season 10 opening episode! Today we’re discussing some of the big updates in metastatic breast cancer research from the 2024 San Antonio Breast Cancer Symposium (SABCS). Joining us today is Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center who will break down into understandable terms some of the most impactful findings shared at SABCS, from advances in endocrine therapy and HER2-targeted treatments to exciting developments in PI3K inhibition and nausea control.
Dr. Bora Lim of MD Anderson Cancer Center joins us to break down the most impactful research and clinical trial updates from the 2025 San Antonio Breast Cancer Symposium. Listen in for expert insight, practical takeaways, and clarity on the evolving MBC treatment landscape.